BIONDVAX PHARMACEUTICALS LTD's ticker is and the CUSIP is 09073Q204. A total of 14 filers reported holding BIONDVAX PHARMACEUTICALS LTD in Q1 2024. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 244,966 | $213,120 | 0.16% |
ARMISTICE CAPITAL, LLC | 362,448 | $315,330 | 0.01% |
WELLS FARGO & COMPANY/MN | 20 | $17 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
UBS Group AG | 824 | $717 | 0.00% |
Global Retirement Partners, LLC | 50 | $38 | 0.00% |
RHUMBLINE ADVISERS | 3,549 | $3,084 | 0.00% |
Aspire Private Capital, LLC | 160 | $139 | 0.00% |
MORGAN STANLEY | 2,282 | $1,985 | 0.00% |
ROYAL BANK OF CANADA | 4 | $0 | 0.00% |